Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03800563 · ClinicalTrials.gov registry record · NA
Laser Assisted Liposuction and Facial Autologous Fat Grafting With the LipoLife System
A NA study of Laser Assisted Liposuction, sponsored by Alma Lasers.
- Completed
- Registry status
- NA
- Development phase
- 20
- Enrollment target
- 2
- Study locations
NCT03800563: Completed NA study of Laser Assisted Liposuction, sponsored by Alma Lasers.
NCT03800563 is a NA study of Laser Assisted Liposuction that has completed, run by Alma Lasers. The registered enrollment target is 20 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (99% lower). The trial reports 2 study locations across 2 states. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT03800563, a NA study of Laser Assisted Liposuction, has completed, sponsored by Alma Lasers.
- COMPLETED
- Registry status
- NA
- Development phase
- 20 participants
- Enrollment target
- 2
- Study locations
Study Summary
Multi-center, prospective, open-label, single arm study. The study aims to evaluate the safety and efficacy of Laser Assisted Liposuction procedure performed with the LipoLife system. The study will include twenty (20) eligible subjects, that are willing to undergo abdominal or outer thighs laser-assisted liposuction. Five to twenty (5-20) subjects out of this study group should also be eligible for facial fat grafting. Follow up visits to evaluate study endpoints will take place at 1, 3 and 6 months after the surgery.
Primary Outcome
Over 90% success in correct identification of before and after body contouring photos by blinded evaluators.
Conditions Studied
Interventions
- DEVICE LipoLife system
Study Locations (2)
Florida
- Sanctuary Plastic Surgery - Boca Raton
Other
- Yitzhak Shamir Medical Center - Be’er Ya‘aqov
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 20 participants |
| Start Date | 2018-11-06 |
| Est. Completion | 2020-05-20 |
| Phase | NA |
What the finished NCT03800563 record still lists
NCT03800563 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 20 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (99% lower).
The record links to 1 condition, with Laser Assisted Liposuction appearing as the primary indexed condition, and to 1 intervention - of which LipoLife system is the first listed.
NCT03800563 reports a single indexed study location in Florida, Other.
Frequently Asked Questions
What is clinical trial NCT03800563 about?
NCT03800563 is a clinical study titled "Laser Assisted Liposuction and Facial Autologous Fat Grafting With the LipoLife System". Multi-center, prospective, open-label, single arm study. The study aims to evaluate the safety and efficacy of Laser Assisted Liposuction procedure performed with the LipoLife system. The study will include twenty (20) eligible subjects, that are willing to undergo abdominal or outer thighs laser-as...
What is the current status of trial NCT03800563?
This trial is currently completed. It is a NA study. The enrollment target is 20 participants. The study started on 2018-11-06. Estimated completion is 2020-05-20.
What conditions does trial NCT03800563 study?
This clinical trial studies the following conditions: Laser Assisted Liposuction.
What interventions are being tested in trial NCT03800563?
The interventions under investigation include: LipoLife system (DEVICE).
Who is sponsoring clinical trial NCT03800563?
This trial is sponsored by Alma Lasers, which has 7 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT03800563 being conducted?
This trial has 2 study locations across Florida. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT03800563's enrollment target sits among peer trials
20 1768th of 2000 higher than 140 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00573339 · 20 participants
Cardiac Magnetic Resonance Imaging (MRI) Normal Reference Control Group Testing
- NCT00692939 · 20 participants · Phase 1
Autologous Stem Cell Transplantation for Crohn's Disease
- NCT00967785 · 20 participants · Phase 1
A Phase I Study of Mozobil in the Treatment of Patients With WHIMS
- NCT01406691 · 20 participants · Phase 4
Light Flashes to Treat Delayed Sleep Phase Disorder (DSPD)
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI